Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer [Phase 4]
Phase IV trial update for panitumumab in Indian subjects with metastatic colorectal cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Effect of Cancer Nurse Navigators on Patient Outcomes [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the impact of cancer nurse navigators on patient outcomes has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial evaluating Reolysin in combination with FOLFOX6 and bevacizumab or FOLFOX6 and bevacizumab alone in metastatic colorectal canc…
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for autologous CAR-T/TCR-T cell immunotherapy targeting multiple malignancies; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors [Phase 1, Phase 2]
A dose-escalation and cohort-expansion study evaluating anti-CD27 (Varlilumab) with anti-PD-1 (Nivolumab) in advanced refractory solid tumor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal Cancer
A completed clinical trial evaluating whether hypertension predicts efficacy of bevacizumab in metastatic colorectal and breast cancer, with…
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Phase II Study to Evaluate the Efficacy and Safety of Fruquintinib Plus Sintilimab as Third-line Therapy for Colorectal Cancer [Phase 2]
Phase II study assessing the combination of Fruquintinib and Sintilimab as third-line therapy for metastatic colorectal cancer.
-
FDA approval · 2019-11-25FDA Approved: ZALTRAP — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Zaltrap (ziv-aflibercept) filed by Sanofi-Aventis U.S. LLC. The action updates the product label…
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer [Phase 3]
Open-label, single-arm Phase 3 trial of BI 695502 in previously untreated metastatic colorectal cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial update evaluating oxaliplatin, 5-FU, and leucovorin with oral capecitabine for metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: mXELOXIRI Combined With Molecular Targeted Drug in mCRC [Phase 2]
Phase 2 trial evaluating mXELOXIRI plus a molecular targeted drug in unresectable metastatic colorectal cancer; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Cancer Associated Thrombosis and Isoquercetin (CATIQ) [Phase 2, Phase 3]
Phase 2/3 clinical trial update for Cancer Associated Thrombosis and Isoquercetin (CATIQ) completed with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC [Phase 2]
Phase 2 trial update comparing CAPOXIRI+Bevacizumab versus FOLFOXIRI+Bevacizumab for metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer [Phase 2]
Phase 2 trial update evaluating cetuximab standard versus dose-escalation in first-line colorectal cancer has completed with results posted.
-
FDA approval · 2019-10-10FDA Approved: CAPECITABINE 150MG — Supplemental Application (Armas Pharmaceuticals Inc.)
The FDA approved a supplemental application to add a 150 mg strength of capecitabine, manufactured by Armas Pharmaceuticals Inc., expanding …
-
FDA approval · 2019-10-09FDA Approved: CAPECITABINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for Capecitabine (CAPECITABINE) from Ascend Laboratories, LLC under ANDA207652.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: A Study for PD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal Cancer [Phase 2]
A Phase 2 study investigating the PD-1 antibody JS001 in MSI-H advanced or recurrent colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Endocuff Vision Colonoscopy vs. AmplifEYE Colonoscopy [NA]
Clinical trial update comparing Endocuff Vision to AmplifEYE during colonoscopy; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer [Phase 2]
Phase 2 trial evaluating GVAX with cyclophosphamide and pembrolizumab in advanced metastatic colorectal cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer [Phase 3]
Phase 3 trial assessing GM1 for prevention of oxaliplatin-induced neurotoxicity in stage II/III colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Improving Goals of Care Discussion in Advanced Cancer Patients [NA]
Clinical trial update reporting completion and results posting for a study focused on improving goals of care discussions in advanced cancer…
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial evaluating Xeliri plus Avastin followed by Xelox plus Avastin (or reverse sequence) in metastatic colorectal cancer; completed…
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Selenium for Prevention of Adenomatous Colorectal Polyps [Phase 3]
Phase 3 trial of selenium for prevention of adenomatous colorectal polyps was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: PERMAD: Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial update for PERMAD exploring personalized marker-driven early switch to aflibercept in metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC) [Phase 2]
Phase 2 trial update evaluating BIBF 1120 vs placebo in chemorefractory metastatic colorectal cancer treated with mFOLFOX6.